Clinical Evaluation of Long-Read Sequencing for Telomere Length Assessment in Human Blood and Lung Tissues
Cells · 26.06.2026 · 15 (13) · 1165
DOI: 10.3390/cells15131165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 26.06.2026. Verfasst von Viviana P Lutzky und 8 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, QLD 4032, Australia. Hauptthemen laut MEDLINE: Lung, Telomere, Telomere Homeostasis. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Prince Charles Hospital Foundation, Medical Research Future Fund, The University of Queensland.
Abstract (Originalsprache)
Telomere length (TL) measurement is increasingly used in the evaluation of pulmonary fibrosis and suspected telomere biology disorders, with flow cytometry–fluorescence in situ hybridisation (Flow-FISH) representing the current clinical reference standard. However, Flow-FISH provides a population-averaged relative TL, has a high analytical variability and is largely restricted to PBMC-based measurements. We evaluated a long-read sequencing–based assay, Telo-Seq, for clinical TL assessment in an Australian cohort. In this observational study, TL was measured by both Flow-FISH and Telo-Seq in PBMC from 156 healthy controls and a small cohort of 24 patients undergoing clinical evaluation for interstitial lung disease, using the same blood processing and assay workflows. In an exploratory subset of samples, TL was also assessed in whole lung lavage fluid and explanted lung tissue. In the assessment of PBMC, Telo-Seq correlated with Flow-FISH (R2 ≈ 0.77) and showed lower inter-assay variability (CV ~1.4% vs. ~4.6%). Classification relative to assay-specific age-adjusted 10th-percentile thresholds was largely concordant between Flow-FISH and Telo-Seq, although discordant cases occurred in both directions near clinically relevant thresholds. Long-read sequencing provides a reproducible approach to TL assessment and supports further evaluation in disease-relevant tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, QLD 4032, Australia.
- School of Medicine, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
- Australian Centre for Cellular Ageing, The Prince Charles Hospital, Brisbane, QLD 4032, Australia.
- Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.
- School of Chemistry & Molecular Biosciences, Faculty of Science, University of Queensland, Brisbane, QLD 4072, Australia.
ORCID-Profile: Subash K Rai, Penny L Groves, Kiara M Knuckey, John A Mackintosh, Simon H Apte
Förderung
- The Prince Charles Hospital Foundation
- Medical Research Future Fund
- The University of Queensland
Zitieren
APA
Lutzky, V. P., Rai, S. K., Tan, M. E., Groves, P. L., Knuckey, K. M., Mackintosh, J. A., Jones, M. J. K., Apte, S. H., & Chambers, D. C. (2026). Clinical Evaluation of Long-Read Sequencing for Telomere Length Assessment in Human Blood and Lung Tissues. Cells, 15(13), 1165. https://doi.org/10.3390/cells15131165
Vancouver
Lutzky VP, Rai SK, Tan ME, Groves PL, Knuckey KM, Mackintosh JA, et al. Clinical Evaluation of Long-Read Sequencing for Telomere Length Assessment in Human Blood and Lung Tissues. Cells. 2026;15(13):1165. doi:10.3390/cells15131165
BibTeX
@article{Lutzky2026,
author = {Lutzky, Viviana P and Rai, Subash K and Tan, Maxine E and Groves, Penny L and Knuckey, Kiara M and Mackintosh, John A and Jones, Mathew J K and Apte, Simon H and Chambers, Daniel C},
title = {Clinical Evaluation of Long-Read Sequencing for Telomere Length Assessment in Human Blood and Lung Tissues},
journal = {Cells},
year = {2026},
volume = {15},
number = {13},
pages = {1165},
doi = {10.3390/cells15131165}
}
EUVIMED